{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:31:38Z","timestamp":1792135898363,"version":"4.4.0"},"reference-count":23,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Presented in this paper is a case of a young Filipino man presenting with recurrent acute gouty flares leading to chronic tophaceous gout and unusual cutaneous manifestations (miliary gout, panniculitis, ulcerations). Unusual sites within the body (torso, shoulder, forearms, thigh) revealed multiple urate dermal deposition. Self-medication with steroids eventually led to secondary Cushing's syndrome and eventual emergence of metabolic complications.<\/jats:p>","DOI":"10.1136\/bcr-2013-009735","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T05:32:10Z","timestamp":1373520730000},"page":"bcr2013009735","source":"Crossref","is-referenced-by-count":15,"title":["\u2018Golden Kernels within the skin\u2019: disseminated cutaneous gout"],"prefix":"10.1136","volume":"2013","author":[{"given":"Tom Edward Ngo","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine Zamora","family":"Racaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Gonzales","family":"Penserga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.1","unstructured":"Schumacher R Chen L . \u2018Gout and other Crystal-associated Arthropathies\u2019 Harrisons\u2019 Principles of internal medicine 17th edn. 2008:2165."},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.2","unstructured":"Miller AV . Gout. http:\/\/emedicine.medscape.com\/article\/329958-clinical . 2011."},{"issue":"2 Suppl","key":"2025042708342563000_2013.jul10_1.bcr2013009735.3","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jaad.2006.04.006","article-title":"Gouty panniculitis in a healthy male","volume":"2013","author":"Dahiya","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/RHU.0b013e3181896921","article-title":"\u2018Gout: an evidence-based review","volume":"2013","author":"Chen","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.5","unstructured":"Bolognia J Braverman I . Skin manifestations of internaldDisease. Harrisons\u2019 principles of internal medicine. 17th edn. McGraw-Hill Professionals 2008:331."},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.6","first-page":"801","article-title":"Gout: an update","volume":"2013","author":"Eggebeen","year":"2007","journal-title":"Am Fam Physician"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.7","first-page":"498","article-title":"Metabolic diseases: gout","volume":"2013","author":"Fallasca","year":"2006","journal-title":"Dermatol Signs Intern Dis"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2310\/7750.2007.00002","article-title":"Miliarial gout (a new entity)","volume":"2013","author":"Shukla","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00296-010-1561-8","article-title":"Panniculitis: another clinical expression of gout","volume":"2013","author":"Ochoa","year":"2011","journal-title":"Rheumatol Int"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.10","first-page":"429","article-title":"Chronic cutaneous gout","volume":"2013","author":"Ebner","year":"1964","journal-title":"Hautarzt"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.11","first-page":"131","article-title":"Severe disseminated cutaneous gout","volume":"2013","author":"Orzan","year":"2012","journal-title":"Acta Endocrinol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"2013","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3810\/pgm.2010.03.2133","article-title":"Diagnosing and treating gout: a review to aid primary care physicians","volume":"2013","author":"Schlesinger","year":"2010","journal-title":"Postgrad Med"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.14","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"2013","author":"Zhang","year":"2006","journal-title":"Ann Rheumatol Dis"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, Randomized, Double-blind, Parallel-Group Trial","volume":"2013","author":"Shaumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.16","first-page":"2093","article-title":"Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study","volume":"2013","author":"Richette","year":"2007","journal-title":"J in Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.17","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"2013","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23007","article-title":"Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout","volume":"2013","author":"Perez-Ruiz","year":"2007","journal-title":"Arthritis Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.19","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"2013","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of Urate-lowering therapy on the velocity of size reduction of size reduction of tophi in chronic gout","volume":"2013","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.21","first-page":"215","article-title":"Hyperuricemia and gout: new insights into pathogenesis and treatment","volume":"2013","author":"Pillinger","year":"2007","journal-title":"Bull NYU Hosp Joint Dis"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","article-title":"Update on gout: new therapeutic strategies and options","volume":"2013","author":"Terkeltaub","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2025042708342563000_2013.jul10_1.bcr2013009735.23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s001050050175","article-title":"Gout tophi and Heberden nodules in hyperuricemia","volume":"2013","author":"Peterseim","year":"1994","journal-title":"Der Hautarzt"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-009735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T15:34:36Z","timestamp":1745768076000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-009735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":23,"alternative-id":["10.1136\/bcr-2013-009735"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-009735","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}